Of note that, rodents are resistant to human insulin and they require significantly higher doses of insulin to reverse hyperglycemia.[50] This reduction in islet mass renews interest in the peritoneal cavity for islet transplantation and potentially for future application with stem cell-derived or xenogeneic cell transplant sources. The gene discussed is INS; the disease is Hyperglycemia.